Crossref
A clinical trial of high-dose growth hormone in a patient with a dominant-negative growth hormone receptor mutation
Yearbook of Paediatric Endocrinology · 30.09.2025
DOI: 10.1530/ey.22.4.10 ↗Kurz gefasst
Fachartikel in der Zeitschrift Yearbook of Paediatric Endocrinology, online erschienen am 30.09.2025. Verfasst von Nadia Merchant und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Merchant, N., Houchin, L., Boucher, K., & Dauber, A. (2025). A clinical trial of high-dose growth hormone in a patient with a dominant-negative growth hormone receptor mutation. Yearbook of Paediatric Endocrinology. https://doi.org/10.1530/ey.22.4.10
Vancouver
Merchant N, Houchin L, Boucher K, Dauber A. A clinical trial of high-dose growth hormone in a patient with a dominant-negative growth hormone receptor mutation. Yearbook of Paediatric Endocrinology. 2025. doi:10.1530/ey.22.4.10
BibTeX
@article{Merchant2025,
author = {Merchant, Nadia and Houchin, Lisa and Boucher, Kimberly and Dauber, Andrew},
title = {A clinical trial of high-dose growth hormone in a patient with a dominant-negative growth hormone receptor mutation},
journal = {Yearbook of Paediatric Endocrinology},
year = {2025},
doi = {10.1530/ey.22.4.10}
}
EUVIMED